MDT · Medtronic plc · Executive Compensation

$102.86 +1.87 (+1.85%) At close · Nov 13 Play latest call Q1 2027 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$131.57B

1.28B

Volume · Nov 13 5.26M Avg daily vol (3M) 16.47M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoff Martha	Chairman and Chief Executive Officer	$1,399,039	—	$13,672,200	$5,175,559	$2,307,200	$386,255	$22,940,252
Thierry Pieton	EVP, Chief Financial Officer	$849,648	$2,000,000	$3,170,470	$1,200,139	$963,050	$404,079	$8,587,387
Brett Wall	Former EVP & President, Neuroscience Portfolio	$799,519	—	$3,566,703	$1,350,152	$824,000	$381,050	$6,921,425
Mike Marinaro	EVP & President Medical Surgical Portfolio & Americas	$819,616	—	$3,566,703	$1,350,152	$971,290	$125,075	$6,832,836
Michelle Quinn	EVP, General Counsel and Secretary	$600,000	$1,100,000	$3,481,600	$750,082	$617,423	$170,065	$6,719,170

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoff Martha	Chairman and Chief Executive Officer	$1,350,000	—	$12,625,000	$4,800,365	$1,883,250	$581,443	$21,240,058
Sean M. Salmon	Former EVP & President, Cardiovascular Portfolio	$884,654	—	$4,537,157	$1,725,131	$823,050	$43,719	$8,396,597
Brett Wall	Former EVP & President, Neuroscience Portfolio	$774,519	—	$4,537,157	$1,725,131	$720,750	$363,656	$8,121,213
Gregory L. Smith	EVP Enterprise Operations	$894,560	—	$4,537,157	$1,725,131	$832,350	$94,784	$8,083,981
Thierry Pieton	Executive Vice President and Chief Financial Officer	$138,517	—	$4,190,625	$600,056	$141,975	$141,274	$5,212,448
Gary L. Corona	Former SVP Corporate Finance (former Interim CFO)	$466,346	—	$3,089,088	$25,002	—	$214,812	$3,795,248
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$262,856	—	—	—	—	$7,823	$270,679

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoff Martha	Chairman and Chief Executive Officer	$1,350,000	—	$12,023,903	$4,499,959	$1,905,272	$305,496	$20,084,630
Robert J. White	Former EVP & President, Medical Surgical Portfolio	$794,539	—	$3,206,416	$1,200,003	$794,539	$3,318,756	$9,314,253
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$911,233	—	$4,408,840	$1,649,997	$943,091	$66,187	$7,979,348
Gregory L. Smith	EVP Enterprise Operations	$872,100	—	$4,706,498	$1,200,003	$820,537	$65,018	$7,664,156
Sean M. Salmon	Former EVP & President, Cardiovascular Portfolio	$867,000	—	$3,406,800	$1,274,992	$774,952	$39,684	$6,548,787
Brett Wall	Former EVP & President, Neuroscience Portfolio	$749,358	—	$3,406,800	$1,274,992	$670,610	$334,272	$6,436,032

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,350,000	—	$9,626,040	$3,975,004	—	$443,588	$15,394,633
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$911,059	—	$3,632,502	$1,500,017	—	$81,181	$6,124,759
Sean M. Salmon	Former EVP & President, Cardiovascular Portfolio	$867,000	—	$2,905,963	$1,200,013	—	$33,968	$5,364,646
Rob ten Hoedt	EVP & President, Global Regions	$907,368	$269,630	$2,470,097	$1,020,004	—	$62,095	$5,047,748
Robert J. White	Former EVP & President, Medical Surgical Portfolio	$794,539	—	$2,905,963	$1,200,013	—	$130,681	$5,031,197

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,345,192	—	$9,762,502	$3,750,293	$2,553,466	$450,497	$17,861,949
Karen Parkhill	Former Executive Vice President and Chief Financial Officer	$901,543	—	$3,670,802	$1,435,118	$1,420,581	$90,611	$7,518,655
Robert J. White	Former EVP & President, Medical Surgical Portfolio	$793,952	—	$3,123,977	$1,225,100	$1,094,944	$115,702	$6,353,675
Rob ten Hoedt	EVP & President, Global Regions	$881,294	—	$2,655,555	$1,045,098	$1,077,580	$62,120	$5,938,889

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey S. Martha	Chairman and Chief Executive Officer	$1,142,308	—	$8,910,812	$4,504,950	$2,740,000	$209,257	$17,507,326
Karen Parkhill	Executive Vice President and Chief Financial Officer	$900,876	—	$3,485,130	$2,145,007	$2,322,211	$68,656	$8,921,879
Robert J. White	EVP & President, Medical Surgical Portfolio	$793,364	—	$2,851,540	$1,745,006	$1,781,315	$82,952	$7,254,177

Executive changes

Person	Role	Change	Effective	Filed
Kendall J. Powell	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Elizabeth G. Nabel, M.D.	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Geoffrey S. Martha	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Kevin E. Lofton	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Joon S. Lee, M.D.	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Gregory P. Lewis	member of the Board of Directors	Already on the board Since at least 2023: re-election or new board role	2026-10-15	2026-10-19
William R. Jellison	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
John P. Groetelaars	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Randall J. Hogan, III	member of the Board of Directors	Already on the board Since at least 2023: re-election or new board role	2026-10-15	2026-10-19
Lidia L. Fonseca	member of the Board of Directors	Already on the board Since at least 2023: re-election or new board role	2026-10-15	2026-10-19
Scott C. Donnelly	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Craig Arnold	member of the Board of Directors	Appointed	2026-10-15	2026-10-19
Michael Marinaro	President, Medtronic	Appointed	2026-10-14	2026-10-19
Kweli Thompson	Executive Vice President and President, Neuroscience Portfolio	Appointed	2026-06-01	2026-05-18
Gregory L. Smith	Executive Vice President, Enterprise Operations	Retired	2025-12-02	2025-11-03
William Jellison	director	Appointed	2025-08-19	2025-08-19
John Groetelaars	director	Appointed	2025-08-19	2025-08-19
Dr. Joon Lee	director	Appointed	2025-06-18	2025-06-23
Skip Kiil	EVP and President, Cardiovascular Portfolio	Appointed	2025-05-21	2025-05-21
Sean Salmon	EVP and President, Cardiovascular Portfolio	Resigned	2025-05-21	2025-05-21
Denise L. Blomquist	Global Controller and Principal Accounting Officer	Appointed	2025-03-17	2025-03-17
Jennifer M. Kirk	Global Controller and Principal Accounting Officer	Resigned	2025-05-02	2025-03-17
Thierry Pieton	Executive Vice President and Chief Financial Officer	Appointed	2025-03-03	2025-01-21
Gary Corona	Interim Chief Financial Officer	Appointed	—	2024-06-26
Karen L. Parkhill	Executive Vice President and Chief Financial Officer	Resigned	2024-08-02	2024-06-26

Leadership

Geoffrey S. Martha CEO, Chairman, Board Member
Omar Ishrak Chairman
Gary Corona CFO
Gary L. Corona CFO
Michelle Quinn General Counsel
Denise L. Blomquist Chief Accounting Officer
Jennifer Kirk Chief Accounting Officer
Andrea J. Goldsmith Board Member
Craig Arnold Board Member
Denise M. O’Leary Board Member
Dr. Joon Lee Board Member
Elizabeth G. Nabel Board Member
Elizabeth G. Nabel, M.D. Board Member
Greg Lewis Board Member
Gregory P. Lewis Board Member
John Groetelaars Board Member
John P. Groetelaars Board Member
Joon Lee Board Member
Joon S. Lee, M.D. Board Member
Kendall J. Powell Board Member
Kevin E. Lofton Board Member
Lidia L. Fonseca Board Member
Randall J. Hogan Board Member
Randall J. Hogan, III Board Member
Richard H. Anderson Board Member
Scott C. Donnelly Board Member
William Jellison Board Member
William R. Jellison Board Member

Key facts CIK 1613103 CUSIP G5960L103 13F (30d) 1690 filings 1598 filers Visit website Investor relations